Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...
The CEO of OpenAI, Sam Altman, is being sued by his sister ... He invested 75 per cent of that money into YC companies, the parent company of Y Combinator. In 2015, Mr Altman was featured on ...
Sam Altman's OpenAI is backing a new AI initiative from a group where John Kerry was a founding member that has voiced ...
And now, after years of stasis in Silicon Valley, we have Sam Altman ... product of unusual self-awareness. Altman, famously, was in the "first class" of Y Combinator, Silicon Valley's ur ...
Immediately following his brief firing from OpenAI, Altman considered starting another AI company, something Chesky and Conway helped talk him out of.
OpenAI CEO Sam Altman sat before Congress in 2023 to testify ... While Altman's investment through Y Combinator was known, his investment through Sequoia was not. OpenAI discloses Altman's ...
2024 The New York Times Company Sam Altman is the co-founder and C.E.O ... Altman was president of the early-stage start-up accelerator Y Combinator from 2014 to 2019. In 2015, Altman ...